# EDGAR Filing Document

**Accession Number:** 0001883788
**File Stem:** 0001641172-25-022673
**Filing Date:** 2025-8
**Character Count:** 10709
**Document Hash:** 2b87657da451049f25fee1e97da3c690
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-022673.hdr.sgml**: 20250808

**ACCESSION NUMBER**: 0001641172-25-022673

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20250804

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250808

**DATE AS OF CHANGE**: 20250808

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DIH HOLDING US, INC.
- **CENTRAL INDEX KEY:** 0001883788
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41250
- **FILM NUMBER:** 251196277

**BUSINESS ADDRESS:**
- **STREET 1:** 77 ACCORD PARK DRIVE, SUITE D-1
- **CITY:** NORWELL
- **STATE:** MA
- **ZIP:** 02061
- **BUSINESS PHONE:** 877-944-2200

**MAIL ADDRESS:**
- **STREET 1:** 77 ACCORD PARK DRIVE, SUITE D-1
- **CITY:** NORWELL
- **STATE:** MA
- **ZIP:** 02061

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Aurora Technology Acquisition Corp.
- **DATE OF NAME CHANGE:** 20210917

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): August 4, 2025**

**DIH HOLDING US, INC.**

**(Exact name of Registrant as Specified in Its Charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41250** | **98-1624542** |
| **(State or Other Jurisdiction**<br> **of Incorporation)** | **(Commission**<br> **File Number)** | **(IRS Employer**<br> **Identification No.)** |

---

---

| | |
|:---|:---|
| **77 Accord Park Drive;**<br> **Suite D-1**<br> **Norwell, Massachusetts** | **02061** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code: 877 944-2200**

**Not Applicable**

**(Former Name or Former Address, if Changed Since Last Report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Class A Common Stock | DHAI | The Nasdaq Stock Market LLC |
| Warrants | DHAIW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers**

(d) On August 4, 2025, the Board of Directors of DIH Holding US, Inc. (the "Registrant"), upon recommendation of the Nominating Committee of the Board, appointed Scott R. Burell to the Board of Directors. He has been appointed to Class III with a term to expire at the 2026 Annual Meeting of Stockholders. He has also been appointed to serve on the Audit, Compensation and Nominating and Corporate Governance Committees. There are no items required to be disclosed by Item 404 of Regulation S-K.

Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Since August 2018, Mr. Burell has served as Chief Financial Officer and Secretary of AIVITA Biomedical, Inc., an immuno-oncology company, Mr. Burell previously served as CFO of CombiMatrix Corporation through its successful acquisition by Invitae Corp.

The Registrant issued a press release on August 7, 2025, announcing the appointment, a copy of which is filed as Exhibit 99.1 hereto and is incorporated herein by reference.

**Item 9.01 Financial Statements and Exhibits.**

**(d) Exhibits.**

---

| | |
|:---|:---|
| **Exhibit** **No.** | **Description** |
| 99.1 | [Press Release dated August 8, 2025](ex99-1.htm) |
| 104 | Cover page interactive data file |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | DIH HOLDING US, INC. | DIH HOLDING US, INC. |
| Date: August 8, 2025 | By: | */s/ Jason Chen* |
|  |  | Jason Chen<br> Chief Executive Officer and Chairman |

---

## Exhibit 99.1

**Exhibit 99.1**

**DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors**

**NORWELL, Mass., August 8, 2025** — DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Scott R. Burell to its Board of Directors.

Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Currently serving as Chief Financial Officer and Secretary of AIVITA Biomedical, Inc., an immuno-oncology company, Mr. Burell previously served as CFO of CombiMatrix Corporation through its successful acquisition by Invitae Corp. He has a proven track record in leading public and private debt and equity financing transactions, corporate reorganizations, and complex M&A activities. Mr. Burell also serves on the Board of Directors of Microbot Medical, Inc. (NASDAQ: MBOT), a medical device company specializing in micro-robotics technologies. He holds Bachelor of Science degrees in Accounting and Business Finance from Central Washington University and is a certified public accountant.

CEO, Jason Chen, stated: "We are pleased to welcome Scott Burell to our Board of Directors. Scott brings exceptional financial acumen and extensive experience in the life sciences sector, having successfully navigated complex transactions and capital market activities throughout his career. His deep understanding of medical technology companies and proven ability to drive value creation will strengthen our board as we continue executing our growth strategy."

Mr. Burell commented on the appointment: "I am pleased to join DIH's Board of Directors and contribute to the company's mission of improving lives through advanced rehabilitation technologies. DIH's position in the growing rehabilitation robotics market presents significant opportunities, and I look forward to working with management and my fellow board members to support the company's continued success and value creation for shareholders."

The Board of Directors now comprises six members, with four independent members, further strengthening the company's commitment to strong governance.

**About DIH Holding US, Inc.**

DIH stands for the vision to "Deliver Inspiration & Health" to improve the daily lives of millions of people with disabilities and functional impairments through providing devices and solutions enabling intensive rehabilitation. DIH is a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Built through the mergers of global-leading niche technology providers, DIH is a transformative rehabilitation solutions provider and consolidator of a largely fragmented and manual-labor-driven industry.

**Caution Regarding Forward-Looking Statements**

This press release contains certain statements which are not historical facts, which are forward-looking statements within the meaning of the federal securities laws, for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These forward-looking statements include certain statements made with respect to the business combination, the services offered by DIH and the markets in which it operates, and DIH's projected future results. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions provided for illustrative purposes only, and projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These risks and uncertainties include, but are not limited to: general economic, political and business conditions; the ability of DIH to achieve its projected revenue, the failure of DIH realize the anticipated benefits of the recently-completed business combination and access to sources of additional debt or equity capital if needed. While DIH may elect to update these forward-looking statements at some point in the future, DIH specifically disclaims any obligation to do so.

**Investor Contact**

Louisa Smith

Investor.relations@dih.com